Radiofrequency (RF) Ablation Prospective Outcomes Study (RAPID)

Boston Scientific

Status: Completed

Conditions: Pain, Chronic

Treatments: Device: Radiofrequency Ablation

Study type: Observational

Funder types: Industry

Identifiers

NCT04673032

A4087

Details and patient eligibility

About

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Enrollment: 298 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

• Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU)
• Signed a valid, IRB/EC/REB-approved informed consent form

Key Exclusion Criteria:

• Meets any contraindications per locally applicable Directions for Use (DFU)
• Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Trial design

298 participants in 1 patient group

Boston Scientific Radiofrequency Ablation Systems

Description:

Subjects with pain treated with a commercially approved Boston Scientific RF system

Treatment:

Device: Radiofrequency Ablation